Expand RVNC Menu
RVNC MENU

RVNC Stock Summary and Trading Ideas (Revance Therapeutics | NASDAQ:RVNC)

Charts for Today's Stock Price and Implied Volatility in Revance Therapeutics

26-Apr-2024

Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for RVNC by Theoretical Edge and Win Rates

Sentiment

Trading Statistics

Key Ratios

Revance Therapeutics (RVNC) Frequently Asked Questions

What does Revance Therapeutics do?

Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.

What symbol and exchange does Revance Therapeutics stock trade?

Revance Therapeutics trades on the NASDAQ stock market under the symbol RVNC.

What is Revance Therapeutics stock price doing today?

As of April 26, 2024, RVNC stock price climbed to $3.40 with 2,192,940 million shares trading.

What is Revance Therapeutics's Beta?

RVNC has a beta of 1.66, meaning it tends to be more sensitive to market movements. RVNC has a correlation of 0.06 to the broad based SPY ETF.

How much is Revance Therapeutics worth?

RVNC has a market cap of $354.33 million. This is considered a Small Cap stock.

How much money does Revance Therapeutics make?

Last quarter Revance Therapeutics reported $70 million in Revenue and -$.62 earnings per share. This beat revenue expectation by $7 million and exceeded earnings estimates by $.10.

What is the highest and lowest price Revance Therapeutics traded in the last 3 year period?

In the last 3 years, RVNC stock traded as high as $37.98 and as low as $3.21.

What are the top ETFs holding Revance Therapeutics?

The top ETF exchange traded funds that RVNC belongs to (by Net Assets): VTI, IWM, VXF, IWO, IBB.

Is Revance Therapeutics (RVNC) a good investment?

RVNC has underperformed the market in the last year with a price return of -89.2% while the SPY ETF gained +27.4%. RVNC has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -43.0% and -17.7%, respectively, while the SPY returned +4.6% and -0.5%, respectively.

What is the support and resistance for Revance Therapeutics (RVNC) stock price?

RVNC support price is $3.15 and resistance is $3.43 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that RVNC stock will trade within this expected range on the day.